BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 12471146)

  • 1. Use of single point mutations in domain I of beta 2-glycoprotein I to determine fine antigenic specificity of antiphospholipid autoantibodies.
    Iverson GM; Reddel S; Victoria EJ; Cockerill KA; Wang YX; Marti-Renom MA; Sali A; Marquis DM; Krilis SA; Linnik MD
    J Immunol; 2002 Dec; 169(12):7097-103. PubMed ID: 12471146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-beta 2-glycoprotein I autoantibodies from patients with the "antiphospholipid" syndrome bind to beta 2-glycoprotein I with low affinity: dimerization of beta 2-glycoprotein I induces a significant increase in anti-beta 2-glycoprotein I antibody affinity.
    Sheng Y; Kandiah DA; Krilis SA
    J Immunol; 1998 Aug; 161(4):2038-43. PubMed ID: 9712077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epitope studies with anti-beta 2-glycoprotein I antibodies from autoantibody and immunized sources.
    Reddel SW; Wang YX; Sheng YH; Krilis SA
    J Autoimmun; 2000 Sep; 15(2):91-6. PubMed ID: 10968891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The orientation of beta2GPI on the plate is important for the binding of anti-beta2GPI autoantibodies by ELISA.
    Iverson GM; Matsuura E; Victoria EJ; Cockerill KA; Linnik MD
    J Autoimmun; 2002 Jun; 18(4):289-97. PubMed ID: 12144810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of 'antiphospholipid' antibodies: a single chromogenic assay of thrombin generation sensitively detects lupus anticoagulants, anticardiolipin antibodies, plus antibodies binding beta(2)-glycoprotein I and prothrombin.
    Sheng Y; Hanly JG; Reddel SW; Kouts S; Guerin J; Koike T; Ichikawa K; Sturgess A; Krilis SA
    Clin Exp Immunol; 2001 Jun; 124(3):502-8. PubMed ID: 11472415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteolytic cleavage of beta(2)-glycoprotein I: reduction of antigenicity and the structural relationship.
    Matsuura E; Inagaki J; Kasahara H; Yamamoto D; Atsumi T; Kobayashi K; Kaihara K; Zhao D; Ichikawa K; Tsutsumi A; Yasuda T; Triplett DA; Koike T
    Int Immunol; 2000 Aug; 12(8):1183-92. PubMed ID: 10917893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beta2-glycoprotein I-dependent anticardiolipin antibodies preferentially bind the amino terminal domain of beta2-glycoprotein I.
    McNeeley PA; Dlott JS; Furie RA; Jack RM; Ortel TL; Triplett DA; Victoria EJ; Linnik MD
    Thromb Haemost; 2001 Aug; 86(2):590-5. PubMed ID: 11522008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Significance of valine/leucine247 polymorphism of beta2-glycoprotein I in antiphospholipid syndrome: increased reactivity of anti-beta2-glycoprotein I autoantibodies to the valine247 beta2-glycoprotein I variant.
    Yasuda S; Atsumi T; Matsuura E; Kaihara K; Yamamoto D; Ichikawa K; Koike T
    Arthritis Rheum; 2005 Jan; 52(1):212-8. PubMed ID: 15641049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunologic characterization and functional properties of murine antibodies raised against deleted mutants of human beta 2-glycoprotein I.
    George J; Blank M; Gilburd B; Hojnik M; Shenkman B; Tamarin I; Varon D; Matsuura E; Koike T; Shoenfeld Y
    Int Immunol; 1997 Jun; 9(6):913-21. PubMed ID: 9199975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-lysobisphosphatidic acid antibodies in patients with antiphospholipid syndrome and systemic lupus erythematosus.
    Alessandri C; Bombardieri M; Di Prospero L; Conigliaro P; Conti F; Labbadia G; Misasi R; Sorice M; Valesini G
    Clin Exp Immunol; 2005 Apr; 140(1):173-80. PubMed ID: 15762889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoantibodies to beta2-glycoprotein I in systemic lupus erythematosus and primary antiphospholipid antibody syndrome: clinical correlations in comparison with other antiphospholipid antibody tests.
    Day HM; Thiagarajan P; Ahn C; Reveille JD; Tinker KF; Arnett FC
    J Rheumatol; 1998 Apr; 25(4):667-74. PubMed ID: 9558167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heterogeneous recognition of beta 2-glycoprotein I by antibodies from antiphospholipid syndrome patients.
    Guerin J; Sim R; Yu BB; Ferluga J; Feighery C; Jackson J
    Thromb Haemost; 2000 Sep; 84(3):374-80. PubMed ID: 11019958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High avidity anti-beta 2-glycoprotein I antibodies in patients with antiphospholipid syndrome.
    Cucnik S; Kveder T; Krizaj I; Rozman B; Bozic B
    Ann Rheum Dis; 2004 Nov; 63(11):1478-82. PubMed ID: 15479898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibodies to Domain I of β(2)Glycoprotein I are in close relation to patients risk categories in Antiphospholipid Syndrome (APS).
    Banzato A; Pozzi N; Frasson R; De Filippis V; Ruffatti A; Bison E; Padayattil SJ; Denas G; Pengo V
    Thromb Res; 2011 Dec; 128(6):583-6. PubMed ID: 21620443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human beta 2-glycoprotein I binds to endothelial cells through a cluster of lysine residues that are critical for anionic phospholipid binding and offers epitopes for anti-beta 2-glycoprotein I antibodies.
    Del Papa N; Sheng YH; Raschi E; Kandiah DA; Tincani A; Khamashta MA; Atsumi T; Hughes GR; Ichikawa K; Koike T; Balestrieri G; Krilis SA; Meroni PL
    J Immunol; 1998 Jun; 160(11):5572-8. PubMed ID: 9605162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluating the conformation of recombinant domain I of β(2)-glycoprotein I and its interaction with human monoclonal antibodies.
    Pericleous C; Miles J; Esposito D; Garza-Garcia A; Driscoll PC; Lambrianides A; Latchman D; Isenberg D; Rahman A; Ioannou Y; Giles I
    Mol Immunol; 2011 Oct; 49(1-2):56-63. PubMed ID: 21899894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Binding of antiphospholipid antibodies to discontinuous epitopes on domain I of human beta(2)-glycoprotein I: mutation studies including residues R39 to R43.
    Ioannou Y; Pericleous C; Giles I; Latchman DS; Isenberg DA; Rahman A
    Arthritis Rheum; 2007 Jan; 56(1):280-90. PubMed ID: 17195232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Binding properties of antibodies to prothrombin and beta2-glycoprotein I (beta2-GPI) assayed by ELISA and dot blot.
    Forastiero RR; Martinuzzo ME; Carreras LO
    Clin Exp Immunol; 1999 Dec; 118(3):480-6. PubMed ID: 10594571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The avidity of anti-beta2-glycoprotein I antibodies in patients with or without antiphospholipid syndrome: a collaborative study in the frame of the European forum on antiphospholipid antibodies.
    Cucnik S; Kveder T; Ulcova-Gallova Z; Swadzba J; Musial J; Valesini G; Avcin T; Rozman B; Bozic B
    Lupus; 2011 Oct; 20(11):1166-71. PubMed ID: 21712304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-beta2-glycoprotein I autoantibodies, in vitro thrombin generation, and the antiphospholipid syndrome.
    Hanly JG; Smith SA
    J Rheumatol; 2000 Sep; 27(9):2152-9. PubMed ID: 10990227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.